MedPath

Lighthouse Project on Dementia, Ulm, Germany

Not Applicable
Conditions
Dementia
Registration Number
NCT00693888
Lead Sponsor
University of Ulm
Brief Summary

The Geriatric Center Ulm scientifically supported a three-year pilot study (ProjektDEMENZ Ulm), in which numerous findings on the system of care regarding people suffering from dementia and their relatives were determined.

One of the most important conclusions is the significant lack of information on the well-functioning network of the care system in Ulm. The full potential of the network is not being exploited.

The situation in the Alb-Donau-Kreis - the area surrounding Ulm - is very similar.

The investigators' aim is to improve the utilization of the system of care for those suffering from dementia in Ulm/Alb-Donau-Kreis by using a newly designed advisory approach (Lighthouse Project on Dementia, Ulm, ULTDEM study).

The purpose of the study is to prove the effectiveness of this procedure by using a prospective, open, randomized, controlled, interventional study.

After the randomization, the interventional group is given comprehensive, individual advice about available treatment possibilities for people suffering from dementia.

In addition, they have the opportunity to re-evaluate their present diagnostic procedure.

The participants of the control group receive the standard treatment. Inclusion criterion is the application of a care level ( level 0 or 1). Recruitment will take one year. A final assessment will be taken every six months.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
200
Inclusion Criteria
  • dementia (MMSE < 24)
  • signing up for classification of care level (0 or 1)
  • community dwelling elderly (older than 60 years)
  • member of certain health insurance provider (AOK, Barmer, DAK)
  • residents of Ulm / Alb-Donau-Kreis
Exclusion Criteria
  • result from the inclusion criteria
  • cancer
  • consuming disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Quality of lifesix months
Secondary Outcome Measures
NameTimeMethod
health economical effects, progress of disease, level of evidence based on diagnosis, institutionalization, hospitalization, using support possibilities, use of drugs6 months

Trial Locations

Locations (1)

Geriatric Center Ulm (GZU), Bethesda Geriatrische Klinik Ulm

🇩🇪

Ulm, Baden-Württemberg, Germany

Geriatric Center Ulm (GZU), Bethesda Geriatrische Klinik Ulm
🇩🇪Ulm, Baden-Württemberg, Germany
Albert Lukas, M.D.
Contact
1149-731-187196
albert.lukas@bethesda-ulm.de
Thorsten Nikolaus, M.D., professor
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.